article thumbnail

Creating intelligence in the pharmaceutical supply chain.

Manufacturing & Logistics IT

Covid-19 is straining supply chains around the world, most notably those of pharmaceutical companies. Control over their supply chain is a major challenge for all pharma companies today. Scarcity of raw materials upstream and overheated demand downstream cause disruptions.

article thumbnail

Expansion of Pharmaceutical Production Drives Automation Use

Automation World

PMMI research highlights how the pharma industry’s efforts to modernize technology and automate at greater levels are being driven by ongoing supply chain issues and plans to provide more sustainable packaging.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Environmental Sensors Increase Supply Chain Visibility

Gary Mintchell

Using these sensors, manufacturers, wholesalers, transportation and logistics operators in the food, pharmaceutical and healthcare industries now have cloud-based visibility into a range of environmental factors, including temperature monitoring and moisture detection.

article thumbnail

Telix Pharmaceuticals expands US operations with new acquisition

Manufacturer's Monthly

Image: Buonaventura/stock.adobe.com Australian company, Telix Pharmaceuticals , has come to an agreement to acquire RLS, an American radio pharmacy network that distribute pharamaecutials such as therapeutic radiopharmaceuticals. This is set to furth enabling the delivery of future clinical and commercial radiopharmaceutical products.

article thumbnail

Emerging Technologies in Pharmaceutical Manufacturing: Modular and Automated Platforms

Frost & Sullivan Manufacturing

In the ever-evolving landscape of pharmaceutical manufacturing, modular and automated platforms are spearheading a transformative shift, particularly in the realm of non-biologics. Robotics streamline procedures, while automation addresses critical challenges such as supply chain disruptions and worker safety.

article thumbnail

Top 10 Strategic Imperatives Shaping the Pharmaceutical Commercialization Solutions and Services Industry

Frost & Sullivan Manufacturing

In the evolving pharmaceutical landscape, a patient-centric care approach is now a key driver of success. This blog delves into the top 10 strategic imperatives transforming pharmaceutical commercialization solutions and services, from the rise of personalized medicine to artificial intelligence (AI)-driven supply chains.

article thumbnail

EU regulation lacks consideration of pharmaceutical industry emissions

E&T

The study has described the current regulation of pharmaceutical companies as being unable to prevent the release of chemicals into the environment throughout the manufacturing supply chain. Moreover, in the EU, it is not possible to refuse the marketing authorisation of human pharmaceuticals based on environmental reasons.